Assessment of Integrated Classifier’s Ability to Distinguish Benign From Malignant Lung Nodules
- 7 November 2020
- journal article
- letter
- Published by Elsevier BV in Social psychiatry. Sozialpsychiatrie. Psychiatrie sociale
- Vol. 159 (3), 1283-1287
- https://doi.org/10.1016/j.chest.2020.10.069
Abstract
No abstract availableFunding Information
- Olympus
- University of Pennsylvania
- Boston University
This publication has 10 references indexed in Scilit:
- Assessment of Plasma Proteomics Biomarker’s Ability to Distinguish Benign From Malignant Lung NodulesSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2018
- Evaluating Molecular Biomarkers for the Early Detection of Lung Cancer: When Is a Biomarker Ready for Clinical Use? An Official American Thoracic Society Policy StatementAmerican Journal of Respiratory and Critical Care Medicine, 2017
- Relationship between nodule count and lung cancer probability in baseline CT lung cancer screening: The NELSON studyLung Cancer, 2017
- An integrated risk predictor for pulmonary nodulesPLOS ONE, 2017
- Recent Trends in the Identification of Incidental Pulmonary NodulesAmerican Journal of Respiratory and Critical Care Medicine, 2015
- The British Thoracic Society guidelines on the investigation and management of pulmonary nodulesThorax, 2015
- Probability of Cancer in Pulmonary Nodules Detected on First Screening CTThe New England Journal of Medicine, 2013
- Evaluation of Individuals With Pulmonary Nodules: When Is It Lung Cancer?Social psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2013
- A Clinical Model To Estimate the Pretest Probability of Lung Cancer in Patients With Solitary Pulmonary NodulesSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2007
- CT Screening for Lung Cancer: Five-year Prospective ExperienceRadiology, 2005